Article

South China Morning Post on 2021-03-04 06:27

India’s Bharat Biotech says its Covaxin coronavirus vaccine is 81 per cent effective

Concerns were raised when the vaccine developed by Bharat Biotech was rolled out for emergency use in January before Phase 3 trials were completed.

Hun Sen

Bharat Biotech

Related news

Covaxin safe for kids: Bharat Biotech The Times of India
Uttarakhand , Mumbai , South Africa , Delhi , Haldwani (Kathgodam)
Bharat Biotech clarifies on COVAXIN usage The Hindu
The Hindu , Delhi , West Bengal , Maharashtra , India
Bharat Biotech terminates Covaxin pact with Brazil partners The Times of India
India , Brazil
Slowing down Covaxin output across plants: Bharat Biotech The Times of India
India
'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
Switzerland , Australia , Montreal , Vancouver , Toronto
Coronavirus | Bharat Biotech to make 6 crore Covaxin doses by July The Hindu
Bangalore , Hyderabad , India , Mumbai , New Delhi
Coronavirus live updates | Bharat Biotech to make 6 crore Covaxin doses by July The Hindu
Austria , Germany , Hyderabad , Mumbai , Brazil
Bharat Biotech says COVID-19 vaccine Covaxin shows 81% interim efficacy The Hindu
The Hindu , India
Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacy The Hindu
Pune , India
COVID-19 vaccination | Use only Covaxin for 15-18 age cohort: Bharat Biotech The Hindu
South-East , Asia , New Delhi
Bharat Biotech begins clinical trials of more effective TB vaccine in India The Times of India
Senegal , Madagascar , South Africa , Paris , Spain
No paracetamol, painkillers needed after Covaxin jab: Bharat Biotech The Hindu
Coronavirus | Covaxin trial participants could test positive, says Bharat Biotech The Hindu
The Hindu , Adar , Moscow , India , Bahrain
Coronavirus | After SII, Bharat Biotech seeks DCGI approval for Covaxin The Hindu
Brazil , Bahrain , United Kingdom , India , Pune
India’s Covaxin COVID-19 vaccine 77.8% effective, Lancet study finds newatlas.com
Russia , China , Philippines , Mexico , Zimbabwe
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech bizjournals.com
Mexico
Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada The Hindu
Hungary , Brazil , India , New Delhi , Canada
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech The Hindu
India
Death of Bhopal volunteer not due to Covaxin, says Bharat BioTech The Hindu
The Hindu , India , Bhopal
Coronavirus | 130 Covaxin trial volunteers may test positive, says Bharat Biotech The Hindu
The Hindu , Adar , Moscow , India , Bahrain